The pathology of familial breast cancer: Immunohistochemistry and molecular analysis (Q24800411)

6 July 2017

1 reference

18 December 2019

The pathology of familial breast cancer: Immunohistochemistry and molecular analysis (English)

1 reference

tumor suppressor proteins

6 July 2017

0 references

1 reference

18 December 2019

1 reference

10 December 2019

1 reference

18 December 2019

1 reference

Osin PP

1

P P

Osin

1 reference

6 July 2017

Lakhani SR

series ordinal

2

author given names

S R

author last names

Lakhani

1 reference

6 July 2017

language of work or name

English

0 references

publication date

27 October 1999

6 references

6 July 2017

13 March 2019

3 April 2019

17 June 2019

10 December 2019

18 December 2019

Breast Cancer Research

6 references

6 July 2017

13 March 2019

3 April 2019

17 June 2019

10 December 2019

18 December 2019

1

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

36-40

1 reference

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Cyclin D1 in breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

p21(WAF1) expression and endocrine response in breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

HER-2/neu (c-erb-B2) gene and protein in breast cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Cathepsin D in cancer metastasis: a protease and a ligand

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Steroid hormone receptors in breast cancer management

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

The relationship between prognostic and predictive factors in the management of breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Prognostic and predictive value of p53 and p21 in breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Family history and survival in premenopausal breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

E-cadherin germline mutations in familial gastric cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Prognostic significance of the estrogen-regulated proteins, cathepsin-D and pS2, in breast cancer.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138499

Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers

30 May 2018

1 reference

Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.

21 January 2018

1 reference

BRCA-associated breast cancer in young women

21 January 2018

1 reference

Expression of pS2 Protein and Estrogen and Progesterone Receptor Status in Breast Cancer

21 January 2018

1 reference

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study

21 January 2018

1 reference

12 December 2020

Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers

1 reference

12 December 2020

Proteases as prognostic markers in cancer

1 reference

12 December 2020

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

12 December 2020

BRCA-associated breast cancer: absence of a characteristic immunophenotype

1 reference

12 December 2020

p53 mutations in BRCA1-associated familial breast cancer

1 reference

12 December 2020

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium

1 reference

12 December 2020

Tumour biological features of BRCA1-induced breast and ovarian cancer

1 reference

12 December 2020

The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas

1 reference

12 December 2020

WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis

1 reference

12 December 2020

Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR11

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference

6 July 2017

1 reference